Profound changes in dopaminergic neurotransmission in the prefrontal cortex in response to flattening of the diurnal glucocorticoid rhythm: Implications for bipolar disorder

Neuropsychopharmacology

Volumn 34, Issue 10, 2009, Pages 2265-2274

  Minton, Gareth O ^a   Young, Allan H ^b   McQuade, Richard ^a   Fairchild, Graeme ^c   Ingram, Colin D ^a   Gartside, Sarah E ^a,d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Corticosteroid; Corticosterone; Dopamine; HPA axis; In situ hybridization histochemistry; Microdialysis; Ventral tegmental area

Indexed keywords

AUTORECEPTOR; DOPAMINE; DOPAMINE AUTORECEPTOR; DOPAMINE UPTAKE INHIBITOR; GLUCOCORTICOID; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; CIRCADIAN RHYTHM; COGNITION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; GENETIC TRANSCRIPTION; HORMONE RELEASE; IN SITU HYBRIDIZATION; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ADRENAL GLANDS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; BUPROPION; CIRCADIAN RHYTHM; CORTICOSTERONE; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; GENE EXPRESSION REGULATION; MALE; MICRODIALYSIS; MONOAMINE OXIDASE; POTASSIUM; PREFRONTAL CORTEX; RATS; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SULPIRIDE; SYNAPTIC TRANSMISSION; TIME FACTORS; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 68949183341     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.53     Document Type: Article

References (87)

1. Ago Y, Nakamura S, Baba A, Matsuda T (2005). Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. Neuropsychopharmacology 30: 43-51.
2. Akesode A, Hendler N, Kowarski A (1976). A 24-hr monitoring of the integrated plasma concentration of aldosterone and cortisol in manic patients. Psychoneuroendocrinology 1: 419-426.
3. Anton R, Kordower JH, Maidment NT, Manaster JS, Kane DJ, Rabizadeh S et al. (1994). Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp Neurol 127: 207-218.
4. Arnsten AF (1997). Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11: 151-162.
5. Arnsten AF, Li BM (2005). Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57: 1377-1384.
6. Baetge EE, Kaplan BB, Reis DJ, Joh TH (1981). Translation of tyrosine hydroxylase from poly(A)-mRNA in pheochromocytoma cells is enhanced by dexamethasone. Proc Natl Acad Sci USA 78: 1269-1273.
7. Barrot M, Abrous DN, Marinelli M, Rouge-Pont F, Le Moal M, Piazza PV (2001). Influence of glucocorticoids on dopaminergic transmission in the rat dorsolateral striatum. Eur J Neurosci 13: 812-818.
8. Barrot M, Marinelli M, Abrous DN, Rouge-Pont F, Le Moal M, Piazza PV (2000). The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci 12: 973-979.
9. Bean AJ, Roth RH (1991). Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors. J Neurosci 11: 2694-2702.
10. Beauregard M, Levesque J, Bourgouin P (2001). Neural correlates of conscious self-regulation of emotion. J Neurosci 21: RC165.
11. Biron D, Dauphin C, Di Paolo T (1992). Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors. Neuroendocrinology 55: 468-476.
12. Blumberg HP, Leung HC, Skudlarski P, Lacadie CM, Fredericks CA, Harris BC et al. (2003). A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 60: 601-609.
13. Brambilla P, Barale F, Soares JC (2003). Atypical antipsychotics and mood stabilization in bipolar disorder. Psychopharmacology (Berl) 166: 315-332.
14. Brodkin ES, Kosten TA, Haile CN, Heninger GR, Carlezon Jr WA, Jatlow P et al. (1999). Dark agouti and Fischer 344 rats: differential behavioral responses to morphine and biochemical differences in the ventral tegmental area. Neuroscience 88: 1307-1315.
15. Brook NM, Cookson IB (1978). Bromocriptine-induced mania? Br Med J 1: 790.
16. Cervantes P, Gelber S, Kin FN, Nair VN, Schwartz G (2001). Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurosci 26: 411-416.
17. Czyrak A, Mackowiak M, Chocyk A, Fijal K, Wedzony K (2003). Role of glucocorticoids in the regulation of dopaminergic neurotransmission. Pol J Pharmacol 55: 667-674.
18. Dalley JW, Cardinal RN, Robbins TW (2004). Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28: 771-784.
19. Dalley JW, Mar AC, Economidou D, Robbins TW (2008). Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav 90: 250-260.
20. DeBattista C (2005). Executive dysfunction in major depressive disorder. Expert Rev Neurother 5: 79-83.
21. Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J et al. (1997). Diurnal activity and pulsatility of the hypothalamus-pituitary- adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 82: 234-238.
22. Devoto P, Flore G, Pani L, Gessa GL (2001). Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry 6: 657-664.
23. Fairchild G, Leitch MM, Ingram CD (2003). Acute and chronic effects of corticosterone on 5-HT1A receptor-mediated autoinhibition in the rat dorsal raphe nucleus. Neuropharmacology 45: 925-934.
24. Faunt JE, Crocker AD (1988). Adrenocortical hormone status affects responses to dopamine receptor agonists. Eur J Pharmacol 152: 255-261.
25. Faunt JE, Crocker AD (1989). Effects of adrenalectomy on responses mediated by dopamine D-1 and D-2 receptors. Eur J Pharmacol 162: 237-244.
26. Fernandez Espejo E (2003). Prefrontocortical dopamine loss in rats delays long-term extinction of contextual conditioned fear, and reduces social interaction without affecting short-term social interaction memory. Neuropsychopharmacology 28: 490-498.
27. Ferrie LJ (2004). The effect of chronic lithium treatment and withdrawal from chronic lithium treatment on mesocorticolimbic dopamine function. PhD thesis Newcastle University, pp 129-134.
28. Floresco SB, Magyar O (2006). Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology (Berl) 188: 567-585.
29. Gerner RH, Post RM, Bunney Jr WE (1976). A dopaminergic mechanism in mania. Am J Psychiatry 133: 1177-1180.
30. Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M (2000). Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology 22: 642-649.
31. Hagerty T, Morgan WW, Elango N, Strong R (2001). Identification of a glucocorticoid-responsive element in the promoter region of the mouse tyrosine hydroxylase gene. J Neurochem 76: 825-834.
32. Haile CN, Hiroi N, Nestler EJ, Kosten TA (2001). Differential behavioral responses to cocaine are associated with dynamics of mesolimbic dopamine proteins in Lewis and Fischer 344 rats. Synapse 41: 179-190.
33. Kaiser S, Unger J, Kiefer M, Markela J, Mundt C, Weisbrod M (2003). Executive control deficit in depression: event-related potentials in a Go/Nogo task. Psychiatry Res 122: 169-184.
34. Kapur S, Mamo D (2003). Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 27: 1081-1090.
35. Kemperman CJ, Zwanikken GJ (1987). Psychiatric side effects of bromocriptine therapy for postpartum galactorrhoea. J R Soc Med 80: 387-388.
36. Kilty JE, Lorang D, Amara SG (1991). Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254: 578-579.
37. Kolur US, Reddy YC, John JP, Kandavel T, Jain S (2006). Sustained attention and executive functions in euthymic young people with bipolar disorder. Br J Psychiatry 189: 453-458.
38. Kumai T, Asoh K, Tateishi T, Tanaka M, Watanabe M, Shimizu H et al. (2000). Involvement of tyrosine hydroxylase up regulation in dexamethasone-induced hypertension of rats. Life Sci 67: 1993-1999.
39. Lampe IK, Sitskoorn MM, Heeren TJ (2004). Effects of recurrent major depressive disorder on behavior and cognitive function in female depressed patients. Psychiatry Res 125: 73-79.
40. Levesque J, Eugene F, Joanette Y, Paquette V, Mensour B, Beaudoin G et al. (2003). Neural circuitry underlying voluntary suppression of sadness. Biol Psychiatry 53: 502-510.
41. Linkowski P (2003). Neuroendocrine profiles in mood disorders. Int J Neuropsychopharmacol 6: 191-197.
42. Linkowski P, Kerkhofs M, Van Onderbergen A, Hubain P, Copinschi G, L'Hermite-Baleriaux M et al. (1994). The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania. Arch Gen Psychiatry 51: 616-624.
43. Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell PB, Vieta E, Sachdev P (2007). Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord 9: 114-125.
44. Martinez-Aran A, Vieta E, Reinares M, Colom F, Torrent C, Sanchez-Moreno J et al. (2004). Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 161: 262-270.
45. McLean A, Rubinsztein JS, Robbins TW, Sahakian BJ (2004). The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology (Berl) 171: 286-297.
46. McTavish SF, McPherson MH, Harmer CJ, Clark L, Sharp T, Goodwin GM et al. (2001). Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 179: 356-360.
47. Mizoguchi K, Ishige A, Takeda S, Aburada M, Tabira T (2004). Endogenous glucocorticoids are essential for maintaining prefrontal cortical cognitive function. J Neurosci 24: 5492-5499.
48. Moghaddam B, Bunney BS (1990). Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 54: 1755-1760.
49. Monsma Jr FJ, McVittie LD, Gerfen CR, Mahan LC, Sibley DR (1989). Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 342: 926-929.
50. Morgan MA, Schulkin J, LeDoux JE (2003). Ventral medial prefrontal cortex and emotional perseveration: the memory for prior extinction training. Behav Brain Res 146: 121-130.
51. Morrow BA, Elsworth JD, Rasmusson AM, Roth RH (1999). The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience 92: 553-564.
52. Nagahama Y, Fukuyama H, Yamauchi H, Matsuzaki S, Konishi J, Shibasaki H et al. (1996). Cerebral activation during performance of a card sorting test. Brain 119: 1667-1675.
53. Ochsner KN, Ray RD, Cooper JC, Robertson ER, Chopra S, Gabrieli JD et al. (2004). For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage 23: 483-499.
54. Ohira H, Nomura M, Ichikawa N, Isowa T, Iidaka T, Sato A et al. (2006). Association of neural and physiological responses during voluntary emotion suppression. Neuroimage 29: 721-733.
55. Ortiz J, DeCaprio JL, Kosten TA, Nestler EJ (1995a). Strain-selective effects of corticosterone on locomotor sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area. Neuroscience 67: 383-397.
56. Ortiz J, Fitzgerald LW, Charlton M, Lane S, Trevisan L, Guitart X et al. (1995b). Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 21: 289-298.
57. Piazza PV, Barrot M, Rouge-Pont F, Marinelli M, Maccari S, Abrous DN et al. (1996). Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc Natl Acad Sci USA 93: 15445-15450.
58. Porter RJ, Bourke C, Gallagher P (2007). Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry 41: 115-128.
59. Pothos EN, Larsen KE, Krantz DE, Liu Y, Haycock JW, Setlik W et al. (2000). Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J Neurosci 20: 7297-7306.
60. Quraishi S, Frangou S (2002). Neuropsychology of bipolar disorder: a review. J Affect Disord 72: 209-226.
61. Robbins TW (2005). Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol 493: 140-146.
62. Robinson JL, Monkul ES, Tordesillas-Gutierrez D, Franklin C, Bearden CE, Fox PT et al. (2008). Fronto-limbic circuitry in euthymic bipolar disorder: evidence for prefrontal hyperactivation. Psychiatry Res 164: 106-113.
63. Rusnak M, Kvetnansky R, Jelokova J, Palkovits M (2001). Effect of novel stressors on gene expression of tyrosine hydroxylase and monoamine transporters in brainstem noradrenergic neurons of long-term repeatedly immobilized rats. Brain Res 899: 20-35.
64. Sachar EJ (1975). Twenty-four-hour cortisol secretory patterns in depressed and manic patients. Prog Brain Res 42: 81-91.
65. Savitz J, Solms M, Ramesar R (2005). Neuropsychological dysfunction in bipolar affective disorder: a critical opinion. Bipolar Disord 7: 216-235.
66. Sawaguchi T, Goldman-Rakic PS (1994). The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 71: 515-528.
67. Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO (1985). A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res 19: 57-64.
68. Schwartz K, Yadid G, Weizman A, Rehavi M (2003). Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression. Brain Res 965: 174-179.
69. Serova L, Sabban EL, Zangen A, Overstreet DH, Yadid G (1998). Altered gene expression for catecholamine biosynthetic enzymes and stress response in rat genetic model of depression. Brain Res Mol Brain Res 63: 133-138.
70. Shoaib M, Shippenberg TS (1996). Adrenalectomy attenuates nicotine-induced dopamine release and locomotor activity in rats. Psychopharmacology (Berl) 128: 343-350.
71. Stephan FK, Zucker I (1972). Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA 69: 1583-1586.
72. Surja AA, Tamas RL, El-Mallakh RS (2006). Antipsychotic medications in the treatment of bipolar disorder. Curr Drug Targets 7: 1217-1224.
73. Tanganelli S, Fuxe K, von Euler G, Eneroth P, Agnati LF, Ungerstedt U (1990). Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis. J Neural Transm Gen Sect 81: 183-194.
74. Tank AW, Curella P, Ham L (1986). Induction of mRNA for tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: evidence for the regulation of tyrosine hydroxylase synthesis by multiple mechanisms in cells exposed to elevated levels of both inducing agents. Mol Pharmacol 30: 497-503.
75. Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN et al. (2005). Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 186: 32-40.
76. Urry HL, van Reekum CM, Johnstone T, Kalin NH, Thurow ME, Schaefer HS et al. (2006). Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults. J Neurosci 26: 4415-4425.
77. Van Kammen DP, Murphy DL (1975). Attenuation of the euphoriant and activating effects of D- and L-amphetamine by lithium carbonate treatment. Psychopharmacologia 44: 215-224.
78. Vlissides DN, Gill D, Castelow J (1978). Bromocriptine-induced mania? Br Med J 1: 510.
79. Wager TD, Smith EE (2003). Neuroimaging studies of working memory: a meta-analysis. Cogn Affect Behav Neurosci 3: 255-274.
80. Wijkstra J, Lijmer J, Balk FJ, Geddes JR, Nolen WA (2006). Pharmacological treatment for unipolar psychotic depression: systematic review and meta-analysis. Br J Psychiatry 188: 410-415.
81. Wilson JM, Sanyal S, Van Tol HH (1998). Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. Eur J Pharmacol 351: 273-286.
82. Windle RJ, Wood SA, Shanks N, Lightman SL, Ingram CD (1998). Ultradian rhythm of basal corticosterone release in the female rat: dynamic interaction with the response to acute stress. Endocrinology 139: 443-450.
83. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P et al. (2000). Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 97: 325-330.
84. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ (1996). Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry 40: 79-88.
85. Zhu MY, Klimek V, Dilley GE, Haycock JW, Stockmeier C, Overholser JC et al. (1999). Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol Psychiatry 46: 1275-1286.
86. Zubieta JK, Taylor SF, Huguelet P, Koeppe RA, Kilbourn MR, Frey KA (2001). Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biol Psychiatry 49: 110-116.
87. Zucker M, Weizman A, Rehavi M (2005). Repeated swim stress leads to down-regulation of vesicular monoamine transporter 2 in rat brain nucleus accumbens and striatum. Eur Neuropsychopharmacol 15: 199-201.